| Primary |
| Product Used For Unknown Indication |
29.3% |
| Urinary Tract Infection |
15.0% |
| Drug Use For Unknown Indication |
14.3% |
| Prostatitis |
7.5% |
| Epididymitis |
3.0% |
| Infection |
3.0% |
| Lower Respiratory Tract Infection |
3.0% |
| Nosocomial Infection |
3.0% |
| Pseudomonas Infection |
3.0% |
| Bronchitis |
2.3% |
| Infection Prophylaxis |
2.3% |
| Pneumonia |
2.3% |
| Anal Abscess |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
| Cellulitis |
1.5% |
| Chest Infection |
1.5% |
| Sinus Infection |
1.5% |
| Staphylococcal Infection |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Urosepsis |
1.5% |
|
| Vomiting |
10.5% |
| Tendonitis |
8.8% |
| Tinnitus |
8.8% |
| Tendon Pain |
7.0% |
| Treatment Failure |
7.0% |
| Weight Decreased |
7.0% |
| Tenosynovitis |
5.3% |
| Labyrinthitis |
3.5% |
| Palpitations |
3.5% |
| Paraesthesia |
3.5% |
| Pollakiuria |
3.5% |
| Purpura |
3.5% |
| Renal Failure Acute |
3.5% |
| Tendon Disorder |
3.5% |
| Thrombotic Thrombocytopenic Purpura |
3.5% |
| Urinary Tract Infection |
3.5% |
| Urosepsis |
3.5% |
| Urticaria |
3.5% |
| Visual Acuity Reduced |
3.5% |
| Visual Impairment |
3.5% |
|
| Secondary |
| Product Used For Unknown Indication |
52.4% |
| Pseudomonas Infection |
6.2% |
| Urinary Tract Infection |
4.8% |
| Suicide Attempt |
4.1% |
| Neutropenic Sepsis |
3.4% |
| Pneumonia |
3.4% |
| Urosepsis |
3.4% |
| Moraxella Infection |
2.8% |
| Anxiety |
2.1% |
| Bordetella Infection |
2.1% |
| Nosocomial Infection |
2.1% |
| Pneumonia Aspiration |
2.1% |
| Prostatitis |
2.1% |
| Abdominal Pain |
1.4% |
| Breast Cancer |
1.4% |
| Diverticulum Intestinal |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Epilepsy |
1.4% |
| Lower Respiratory Tract Infection |
1.4% |
| Pneumonia |
0.7% |
|
| Vomiting |
14.7% |
| Urosepsis |
8.8% |
| Wheezing |
8.8% |
| Nosocomial Infection |
5.9% |
| Pneumonia |
5.9% |
| Respiratory Tract Infection |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Urinary Tract Infection |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Acquired Haemophilia |
2.9% |
| Clostridial Infection |
2.9% |
| Clostridium Difficile Infection |
2.9% |
| Drug Administration Error |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Drug Ineffective |
2.9% |
| Idiopathic Thrombocytopenic Purpura |
2.9% |
| Intestinal Perforation |
2.9% |
| Neuropathy Peripheral |
2.9% |
| No Therapeutic Response |
2.9% |
| Peritonitis Bacterial |
2.9% |
|
| Concomitant |
| Plasma Cell Myeloma |
13.4% |
| Acute Myeloid Leukaemia |
9.8% |
| Mantle Cell Lymphoma |
8.5% |
| Drug Use For Unknown Indication |
7.3% |
| Osteoporosis |
7.3% |
| Chronic Myeloid Leukaemia |
6.1% |
| Osteopenia |
6.1% |
| Encephalitis Viral |
4.9% |
| Prophylaxis Of Nausea And Vomiting |
4.9% |
| Immunodeficiency Common Variable |
3.7% |
| Infection |
3.7% |
| Product Used For Unknown Indication |
3.7% |
| Sinusitis |
3.7% |
| Aplastic Anaemia |
2.4% |
| Blood Pressure |
2.4% |
| Bone Marrow Failure |
2.4% |
| Chemotherapy |
2.4% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Head And Neck Cancer |
2.4% |
| Hypogammaglobulinaemia |
2.4% |
|
| Tachycardia |
13.2% |
| White Blood Cell Count Decreased |
13.2% |
| Vomiting |
7.9% |
| Mouth Ulceration |
5.3% |
| Renal Failure Acute |
5.3% |
| Stress Fracture |
5.3% |
| Subdural Haematoma |
5.3% |
| Tardive Dyskinesia |
5.3% |
| Urinary Tract Infection |
5.3% |
| Urticaria |
5.3% |
| Weight Decreased |
5.3% |
| Acute Generalised Exanthematous Pustulosis |
2.6% |
| Blood Triglycerides Increased |
2.6% |
| Blood Urea Increased |
2.6% |
| Cataract |
2.6% |
| Constipation |
2.6% |
| Dizziness |
2.6% |
| Drug Dose Omission |
2.6% |
| Drug Ineffective |
2.6% |
| Fatigue |
2.6% |
|
